Many studies have shown the efficacy and benefits of early percutaneous coronary intervention (PCI) as well as the subsequent combination of fibrinolytic agents (FA) and PCI in patients with acute ST-elevation myocardial infarction based on some criteria such as overall mortality, secondary MI and stroke.